Cytokinetics, Incorporated
Financial ratios & Valuation

Forward Multiples (2025 – 2028)

2025202620272028
Price/Earnings ratio
-8.75-14.15105.5111.22
Price/Sales ratio
44.508.453.592.08
Earnings per Share (EPS)
$-4.41$-2.73$0.36$3.44

Historical Multiples (2014 – 2023)

2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 TTM Median
Valuation Ratios
Price/Earnings ratio
-19.52-10.7829.49-3.15-3.23-4.09-8.16-14.45-10.22-15.31-13.28-4.09
Price/Sales ratio
6.0914.114.5630.1110.9122.7324.0149.7543.511.07K36.0810.91
Price/Book Value ratio
3.105.895.143.6613.26-55.8511.8214.37-38.14-20.86-30.97-55.85
Price/Cash Flow ratio
-6.3782.8113.12-3.95-3.39-6.71149.92-24.58-13.74-19.45-11.15-6.71
Price/Free Cash Flow ratio
-6.2293.5813.71-3.84-3.36-6.53-635.75-18.31-13.24-19.38-10.75-6.53
Price/Earnings Growth ratio
0.29-0.07-0.200.000.13-0.124.23-0.60-0.24-0.700.140.13
Dividend Yield
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Profitability Indicator Ratios
Gross Profit Margin
5.35%-61.90%43.70%-575.46%-182.95%-220.54%-73.66%-127.09%-154.59%-4284.10%-78.98%-182.95%
Operating Profit Margin
-31.43%-130.52%17.56%-848.26%-282.26%-367.97%-168.27%-264.54%-342.75%-6589.70%-212.85%-282.26%
Pretax Profit Margin
-31.20%-130.85%15.46%-955.93%-337.41%-452.92%-228.00%-305.72%-411.20%-6988.63%-271.58%-337.41%
Net Profit Margin
-31.20%-130.85%15.46%-955.93%-337.41%-554.75%-294.00%-344.13%-425.58%-6988.63%-271.58%-337.41%
Effective Tax Rate
3.34%1.57%-4.50%-0.53%-3.94%-22.48%-28.94%-12.56%-3.49%N/AN/A-3.94%
Return on Assets
-11.01%-32.54%9.67%-43.34%-50.33%-51.43%-30.74%-28.80%-39.66%-63.84%-24.79%-50.33%
Return On Equity
-15.90%-54.67%17.43%-116.33%-409.84%1362.82%-144.76%-99.38%373.07%136.21%-969.47%1362.82%
Return on Capital Employed
-13.52%-44.75%13.65%-43.22%-47.04%-37.47%-18.69%-24.21%-34.85%-68.76%-21.19%-47.04%
Liquidity Ratios
Current Ratio
5.493.574.768.459.358.9815.19N/AN/AN/A9.399.35
Quick Ratio
5.493.574.768.459.668.9815.348.179.396.119.259.25
Cash ratio
0.842.052.013.851.901.402.651.560.771.100.771.40
Days of Sales Outstanding
362.710.150.0830.3678.6170.1328.89268.550.5662.190.5770.13
Days of Inventory outstanding
0.00N/AN/A0.00-27.78N/A-16.64-118.25-0.22N/AN/A-27.78
Operating Cycle
362.710.150.0830.3650.8370.1312.25150.290.3462.190.1470.13
Days of Payables Outstanding
11.1817.6025.8121.2315.4134.5830.3048.1238.8123.7756.3815.41
Cash Conversion Cycle
351.53-17.45-25.739.1235.4235.55-18.04102.17-38.4738.41-55.8035.55
Debt Ratios
Debt Ratio
N/A0.120.170.100.200.460.250.180.610.771.100.20
Debt Equity Ratio
N/A0.210.310.281.63-12.241.220.64-5.76-1.64-10.40-12.24
Long-term Debt to Capitalization
N/A0.170.220.220.601.090.540.361.212.741.190.60
Total Debt to Capitalization
N/A0.170.240.220.621.080.540.391.202.551.180.62
Interest Coverage Ratio
N/A-149.626.92-6.67-4.12-3.61-2.42N/AN/AN/A-5.65-3.61
Cash Flow to Debt Ratio
N/A0.331.23-3.20-2.38-0.670.06-0.90-0.48-0.65-0.43-2.38
Company Equity Multiplier
1.441.681.802.688.14-26.494.703.44-9.40-2.13-9.40-26.49
Cash Flow Ratios
Operating Cash Flow / Sales Ratio
-0.950.170.34-7.61-3.21-3.380.16-2.02-3.16-55.02-3.23-3.38
Free Cash Flow / Operating Cash Flow Ratio
1.020.880.951.021.001.02-0.231.341.031.001.031.00
Cash Flow Coverage Ratio
N/A0.331.23-3.20-2.38-0.670.06-0.90-0.48-0.65-0.43-2.38
Short Term Coverage Ratio
N/AN/A14.79N/A-38.82-19.693.21-9.58-23.34-14.81-23.34-38.82
Dividend Payout Ratio
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A